Bevacizumab in the treatment of non-small cell lung cancer with brain metastases / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 864-865, 2017.
Artigo
em Chinês
| WPRIM
| ID: wpr-666237
ABSTRACT
The occurrence of brain metastases in lung cancer affects the prognosis of patients.Following surgery,whole brain radiotherapy,stereotactic radiotherapy and chemotherapy,anti-angiogenesis therapy has become a new treatment option for lung cancer patients with brain metastases.As an anti-angiogenic drug,bevacizumab has a better effect of controlling peritumoral edema.Studies have shown that bevacizumab combined with chemotherapy,radiotherapy to treat non-small cell lung cancer with brain metastasis has a good efficacy and safety.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of International Oncology
Ano de publicação:
2017
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS